Newsfeeds - Spark Newswire

1 minute read

Wells Fargo Downgrades Edwards Lifesciences to Equal-Weight, Lowers Price Target to $78

Today, 5:02 PM

Wells Fargo analyst Larry Biegelsen downgrades Edwards Lifesciences (NYSE:EW) from Overweight to Equal-Weight and lowers the price target from $97 to $78.

1 minute read

Raymond James Downgrades Edwards Lifesciences to Market Perform

By Benzinga Newsdesk

Today, 5:02 PM

Raymond James analyst Jayson Bedford downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Market Perform.

1 minute read

Canaccord Genuity Maintains Hold on Edwards Lifesciences, Raises Price Target to $76

By Benzinga Newsdesk

Today, 5:02 PM

Canaccord Genuity analyst William Plovanic maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target from $68 to $76.

1 minute read

Edwards Lifesciences Q4 Earnings Beats Street Estimates, Expects Easing Of Macro Headwinds Later In 2023

By Vandana Singh

Today, 5:02 PM

Edwards Lifesciences Corp (NYSE:EW) reported Q4 adjusted EPS of $0.64, up 25% Y/Y and higher than the consensus of $0.61.…

1 minute read

Edwards Lifesciences Sees FY23 Sales $5.6B-$6B Vs $5.78B Est; Q1 2023 EPS $0.58-$0.64 Vs $0.59 Est; Q1 2023 Revenue $1.37B-$1.45B Vs $1.37B Est

By Happy Mohamed

Today, 5:02 PM

Outlook Overall, the company is reaffirming the sales guidance it provided at the December investor conference for all product groups. Full year 2023 sales are expected to grow 9 to 12